| Íàèìåíîâàíèå | Ïðîèçâîäèòåëü | Öåíà $ | Öåíà ðóá
|
|---|
| ÑÀËÈÖÈËÎÂÀß Ê-ÒÀ Ð-Ð ÑÏÈÐÒ. 2% ÔË.40ÌË | 0 | | 943
|
| ÑÀËÜÁÓÒÀÌÎË ÀÝÐ.12ÌË | ÀËÒÀÉÂÈÒÀÌÈÍÛ | | 944
|
| ÑÀÍÀÐÈÍ-ÀÍÀËÅÐÃÈÍ ÔË.10ÌË | GALENA | | 945
|
| ÑÀÍÎÐÈÍ ÝÌÓËÜÑÈß 10ÌË 0.05% | GALENA | | 947
|
| ÑÀÍÎÐÈÍ ÝÌÓËÜÑÈß 10ÌË 0.1% | GALENA | | 946
|
| ÑÀÐÈÄÎÍ ÒÀÁË. ¹10 | ROCHE-NICHOLAS | | 948
|
| ÑÂÅ×È Ñ ÈÍÒÎÌÈÖÈÍÎÌ 0.25à ¹10 | ÁÈÎÑÈÍÒÅÇ | | 949
|
| ÑÂÅ×È Ñ ÏÀÏÀÂÅÐÈÍÀ Ã/ÕË. 0.02à ¹10 | ÁÈÎÑÈÍÒÅÇ | | 950
|
| ÑÅÁÈÄÈÍ ÒÀÁË. ¹20 | GLAXO WELLCOME | | 951
|
| ÑÅÄÀËÜÃÈÍ ÍÅÎ ÒÀÁË. ¹10 | PHARMACIA AD | | 952
|
| ÑÅÍÀÄÅ ÒÀÁË. ¹500 | CIPLA | | 953
|
| ÑÅÏÒÎËÅÒÅ ÏÀÑÒÈËÊÈ ¹30 | KRKA | | 954
|
| ÑÅÏÒÐÈÍ ÒÀÁË.480ÌÃ ¹20 | GLAXO WELLCOME | | 955
|
| ÑÅÐÌÈÎÍ ÒÀÁË.10ÌÃ ¹50 | PHARMICA & UPJOHN | | 956
|
| ÑÅÐÍÀß ÌÀÇÜ ÏÐÎÑÒÀß 25Ã | ÒÂÅÐÑÊÀß ÔÔ | | 957
|
| ÑÈÍÀÔËÀÍÀ ÌÀÇÜ 0.025% 10Ã | ÀËÒÀÉÂÈÒÀÌÈÍÛ | | 958
|
| ÑÈÍÀÔËÀÍÀ ÌÀÇÜ 0.025% 10Ã | ÁÐÛÍÖÀËÎÂ-À ÇÀÎ | | 959
|
| ÑÈÍÀÔËÀÍÀ ÌÀÇÜ 0.025% 15Ã | ÁÐÛÍÖÀËÎÂ-À ÇÀÎ | | 960
|
| ÑÈÍÝÑÒÐÎË Ð-Ð 0.1% ÀÌÏ.1ÌË ¹10 | 0 | | 962
|
| ÑÈÍÝÑÒÐÎË Ð-Ð 2% ÀÌÏ.1.0ÌË ¹10 | ÔÀÐÌÀÄÎÍ | | 961
|
| ÑÈÑÒÅÌÛ Ä/ÈÍÔÓÇ."ÀÕËÊÎÄÐÈÏ" ÈÍÄÈß | 0.15 USD | | 963
|
| ÑÈÑÒÅÌÛ Ä/ÈÍÔÓÇ."ÊÄÌ" ÃÅÐÌÀÍÈß | 0.175 USD | | 964
|
| ÑÈÑÒÅÌÛ ÏÅÐÅËÈÂÀÍ. ÈÍÔÓÇÈÎÍ.ÏÊ 21-01 ØÒ | ÄÀËÜÍÅÂÎÑÒ. ÌÅÄ. ÑÈÑÒ. | | 965
|
| ÑÈÑÒÅÌÛ ÏÅÐÅËÈÂÀÍ. ÒÐÀÍÑÔÓÇ.ÏÊ 21-01 ØÒ | ÄÀËÜÍÅÂÎÑÒ. ÌÅÄ. ÑÈÑÒ. | | 966
|
| ÑÌÅÊÒÀ ÏÎÐÎØÎÊ ¹10 | BEAUFOUR IPSEN | | 968
|
| ÑÌÅÊÒÀ ÒÀÁË.3Ã ¹30 | BEAUFOUR IPSEN | | 967
|
| ÑÎËÊÎÑÅÐÈË ÀÌÏ.25Õ2ÌË | SOLCO BASEL AG | | 971
|
| ÑÎËÊÎÑÅÐÈË ÃÅËÜ 10% 20Ã | SOLCO BASEL AG | | 969
|
| ÑÎËÊÎÑÅÐÈË ÃË.ÃÅËÜ 5Ã | SOLCO BASEL AG | | 972
|
| ÑÎËÊÎÑÅÐÈË ÌÀÇÜ 5% 20Ã | SOLCO BASEL AG | | 970
|
| ÑÎËÎÄÊÈ ÊÎÐÍß ÑÈÐÎÏ ÔË. 100Ã | 0 | | 973
|
| ÑÎËÏÀÄÅÈÍ ÊÀÏÑ.¹12 | SMITH KLINE BEECHAM | | 975
|
| ÑÎËÏÀÄÅÈÍ ÒÀÁË.¹6 | SMITH KLINE BEECHAM | | 974
|
| ÑÎËÏÀÔËÅÊÑ ÊÀÏÑ.300Ã ¹12 | SMITH KLINE BEECHAM | | 976
|
| ÑÎÐÁÈÒ ÃÐÀÍÓËÈÐÎÂÀÍÍÛÉ 350Ã | ICN ÌÀÐÁÈÎÔÀÐÌ | | 977
|
| ÑÎÐÁÈÔÅÐ ÄÓÐÓËÅÊÑ ÒÀÁË. ¹50 | EGIS | | 978
|
| ÑÎÔÐÀÄÅÊÑ ÊÀÏËÈ 5ÌË | AVENTIS PHARMA | | 979
|
| ÑÏÀÇÃÀÍ ÀÌÏ.5ÌË ¹5 | WOCKHARDT | | 981
|
| ÑÏÀÇÃÀÍ ÒÀÁË.500ÌÃ ¹20 | WOCKHARDT | | 980
|
| ÑÏÀÇÃÀÍ ÒÀÁË.500ÌÃ ¹20 | WOCKHARDT | | 982
|
| ÑÏÀÇÌÀËÃÎÍ ÀÌÏ.5ÌË | SOPHARMA | | 984
|
| ÑÏÀÇÌÀËÃÎÍ ÒÀÁË. ¹20 | PHARMICIA AD | | 983
|
| ÑÏÀÇÌÎÀÍÀËÜÃÀÍ (ÁÀÐÀËÃÈÍ) ÒÀÁË.500Ìà ¹100 | ÃÎÑÍÈÈ ÁÈÎËÎÃÈ×. ÏÐÈÁÎÐÎÑÒÐÎÅÍÈß | | 985
|
| ÑÏÀËÃÈÍ ÔÎÐÒÅ ÒÀÁË.¹10 | ÁÐÛÍÖÀËÎÂ-À ÇÀÎ | | 986
|
| ÑÏÈÐÀËÜ Â/Ì 0 | ÊÎÏÅÐ | | 987
|
| ÑÏÈÐÎÔÈÒ (ÑÏËÀÒ) ÒÀÁË.0.3Ã ¹28 | ÔÀÐÌÀÒÅÕ | | 988
|
| ÑÒÎÏÀÍÃÈÍ ÔË.100ÌË | GALENA | | 989
|
| ÑÒÎÏÒÓÑÑÈÍ ÊÀÏËÈ 10ÌË | GALENA | | 990
|
| ÑÒÎÏÒÓÑÑÈÍ ÒÀÁË. ¹20 | GALENA | | 991
|
| ÑÒÎÏÒÓÑÑÈÍ-ÔÈÒÎ ÑÈÐÎÏ 100ÌË ÔË. | GALENA | | 992
|
| ÑÒÐÅÏÑÈËÑ ÌÅÄÎÂÎ-ËÈÌÎÍÍÛÅ ÏÀÑÒÈËÊÈ ¹24 | BOOTS HEALTHCARE INTERNATIONAL | | 994
|
| ÑÒÐÅÏÑÈËÑ ÌÅÍÒÎËÎÂÎ-ÝÂÊÀËÈÏÒÎÂÛÅ ÏÀÑÒÈËÊÈ ¹24 | BOOTS HEALTHCARE INTERNATIONAL | | 995
|
| ÑÒÐÅÏÑÈËÑ ÎÐÈÃÈÍÀËÜÍÛÅ ÏÀÑÒÈËÊÈ ¹24 | BOOTS HEALTHCARE INTERNATIONAL | | 993
|
| ÑÒÐÅÏÑÈËÑ Ñ ÂÈÒ. Ñ ÏÀÑÒÈËÊÈ ¹24 | BOOTS HEALTHCARE INTERNATIONAL | | 996
|
| ÑÒÐÅÏÒÎÌÈÖÈÍÀ ÑÓËÜÔÀÒ 1.0 ÔË. | ÁÐÛÍÖÀËÎÂ-À ÇÀÎ | | 997
|
| ÑÒÐÅÏÒÎÖÈÄ ÒÀÁË.0.5Ã ¹10 | ÓÑÎËÜÅ-ÑÈÁÈÐÑÊÈÉ ÕÔÊ | | 998
|
| ÑÒÐÅÏÒÎÖÈÄÎÂÀß ÌÀÇÜ ÌÀÇÜ 10% 25Ã | ÈÂÀÍÎÂÑÊÀß ÔÔ | | 999
|
| ÑÒÓÃÅÐÎÍ ÒÀÁË.25ÌÃ ¹50 | GEDEON RICHTER | | 1000
|
| ÑÓËÜÔÀÖÈË ÍÀÒÐÈÉ 20% ÒÞÁ/ÊÀÏ ¹2 | ÁÅËÌÅÄÏÐÅÏÀÐÀÒÛ | | 1001
|
| ÑÓËÜÔÀÖÈË ÍÀÒÐÈß ÃË.ÊÀÏËÈ 20% ÒÞÁ/ÊÀÏ ¹1 | 0 | | 1002
|
| ÑÓÌÀÌÅÄ ÊÀÏÑ.250ÌÃ ¹6 | PLIVA | | 1004
|
| ÑÓÌÀÌÅÄ ÒÀÁ.500ÌÃ ¹3 | CIPLA | | 1003
|
| ÑÓÌÀÌÎÊÑ(ÀÇÈÒÐÎÌÈÖÈÍ) ÊÀÏÑ.250ÌÃ ¹6 | OXFORD LABORATORIES | | 1005
|
| ÑÓÌÈà (ÑÓÌÀÒÐÈÏÒÀÍ) 100Ìà ¹2 | ÌÀÐÈ×È ÝÊÑÏÎÐÒÑ ÏÂÒ.ËÒÄ | | 1006
|
| ÑÓÌÈà (ÑÓÌÀÒÐÈÏÒÀÍ) 50Ìà ¹2 | ÌÀÐÈ×È ÝÊÑÏÎÐÒÑ ÏÂÒ.ËÒÄ | | 1007
|
| ÑÓÏÐÀÑÒÈÍ ÀÌÏ.1ÌË ¹5 | EGIS | | 1009
|
| ÑÓÏÐÀÑÒÈÍ ÒÀÁË.25ÌÃ ¹20 | EGIS | | 1008
|
| ÑÓÏÐÈÌÀ-ÏËÞÑ ÌÀÇÜ 20.0 | ØÐÅß ÕÅËÑÊÅÐ ÏÂÒ ËÒÄ. | | 1010
|
| ÑÓÑÒÀÊ-ÌÈÒÅ ÒÀÁË.2,6ÌÃ ¹25 | ÀÊÐÈÕÈÍ ÕÔÊ | | 1011
|
| ÑÓÑÒÀÊ-ÔÎÐÒÅ ÒÀÁË.6,4ÌÃ ¹25 | ÂÅÊÒÎÐ-ÔÀÐÌ | | 1012
|
